A new startup from Portugal, Mondego Bio, is working on innovative cancer treatments. The company was established by three investors and is the first investment made by Biovance Capital Fund I. The announcement was made in Lisbon, Portugal on September 18, 2025. Biovance Capital Partners, a biotech venture firm, is actively involved in this initiative.